Skip to main content

Table 2 Crude efficacy (not PCR-adjusted), number and quotients of failures by Day and drug categories within 28 days*

From: Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

 

artesunate amodiaquine combinations

Other ACT

non-ACT

Day of censure

Failure (n)

Total follow-up

Quotient Day(x)

Free of failure

Failure (n)

Total follow-up

Quotient Day(x)

Free of failure

Failure (n)

Total follow-up

Quotient Day(x)

Free of failure

0

77

5942

0.013

987

8

2769

0.003

997

11

2926

0.004

996

1

24

5839

0.004

983

8

2746

0.003

994

16

2912

0.005

991

2

4

5806

0.001

982

3

2736

0.001

993

22

2895

0.008

983

3

1

5774

0.000

982

1

2729

0.000

993

24

2868

0.008

975

7

5

5745

0.001

981

2

2720

0.001

992

86

2824

0.030

945

14

103

5675

0.018

964

22

2700

0.008

984

228

2703

0.084

866

21

531

5477

0.097

871

147

2653

0.055

929

491

2419

0.203

690

28

490

4874

0.101

783

260

2479

0.105

832

360

1895

0.190

559

Total

1235

5942

  

451

2769

  

1238

2926

  
  1. *Note: this table does not refer to randomized comparative trials therefore direct comparisons between drug categories in this table are not legitimate. ACT: artemisinin combination therapy.